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Purpose: The clinical outcomes of scaphotrapeziotrapezoid (STT) arthrodesis were compared to radial shortening
osteotomy (RSO) to determine if any of the treatment methods was superior. The impact of RSO and vascularized
bone grafts (VBG) on disease progression were measured based on X-rays to evaluate if a difference in Kienböck’s
disease (KD) progression exists.
Methods: Out of 98 consecutive patients treated between 1991 and 2013, 46 had STT arthrodesis, 21 had RSO, 7
had VBG, and 3 had VBG and RSO. Patients treated with STT arthrodesis were compared to RSO regarding post-
operative range of motion (ROM), wrist pain on the Numeric Rating Scale (NRS), grip strength, duration of incapacity
for work, the Disabilities of the Arm, Shoulder, and Hand (DASH), and the Modified Mayo Wrist scores (MMWS).
Radiographic assessment (Nattrass index, radioscaphoid angle, and Ståhl index) was performed to determine disease
progression following RSO or VBG. Baseline patient characteristics were comparable in all treatment groups.
Results: There were no significant differences in post-operative ROM, wrist pain, grip strength, duration of incapacity,
DASH score, or MMWS score following STT arthrodesis (n = 27) or RSO (n = 14). The Ståhl index, the Nattrass index, and
the radioscaphoid angle suggested disease progression following RSO (n = 14) and/or VBG (n = 6) although the
changes were not significant.
Conclusions: The study failed to demonstrate clinically relevant differences between STT arthrodesis compared
to RSO. No evidence was found that decompression or revascularization, or the combination of the two, can
reverse or halt the course of the disease.
Level of evidence: Therapy, level III, retrospective comparative study with prospectively collected data.
Keywords: Lunate necrosis, Kienböck’s disease, Osteonecrosis, Kienböck, Case control study, Radial shortening
osteotomy, Vascularized bone graft, Scaphotrapeziotrapezoid arthrodesisIntroduction
Treatments for Kienböck’s disease (KD) can be grouped
into three categories: symptomatic, salvage, and causal.
Symptomatic treatment like wrist denervation is ex-
pected to decrease pain, and salvage procedures like sca-
photrapeziotrapezoid (STT) arthrodesis are anticipated
to prevent the onset of arthritis thereby prolonging wrist
function in time, while causal treatments like radial
shortening osteotomy (RSO) and/or vascularized bone* Correspondence: stephane.stahl@gmail.com
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of the disease.
Recent case–control studies [1, 2], systematic reviews
[2, 3], and a meta-analysis [2] have shown that neither
high-level nor good quality scientific evidence exists to
support any of the hypotheses regarding the etiology of
KD published in the literature. Therefore, causal treat-
ment of KD has to be critically evaluated on the basis of
evidence of restored trabecular architecture, lunate
shape and wrist geometry (effectiveness), and a superior
success rate compared to other treatments in compara-
tive studies (efficacy).
In a systematic review of 205 articles on the treatment
of KD, salvage and causal treatment options presentedis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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across treatments were not possible. Surgical treatments
of rare diseases usually lack controlled trials and formal
statistical analyses; thus, physicians base their clinical
judgments solely on potentially biased observational
studies, experience, or anecdote [5]. Few studies present
objective and adequate parameters to verify if the surgi-
cal treatment achieved the goal for which it was indi-
cated [4], and even fewer studies compare the outcomes
of two different procedures.
The purpose of this study was to perform a comparative
analysis of the clinical outcome of STT arthrodesis vs.
RSO using a standardized self-assessment questionnaire, a
face-to-face interview and clinical measurements to deter-
mine if one treatment method was more effective than
another. Furthermore, the pre- and post-operative radio-
logical parameters associated with RSO and VBG were
compared by three independent surgeons to determine if
their impact on disease progression differed.
Patients and methods
Patients
The study was conducted with the approval of the Ethics
Review Board of Eberhard-Karls-University, Tuebingen,
Germany (approval number 176/2009BO1).
Between January 1990 and October 2013, 98 consecu-
tive patients, treated for the first time for KD, were iden-
tified based on an electronic archive of a large teaching
hospital (of more than 1800 beds) certified as a level-I
trauma center. All patients were included who had a
documented clinical examination, a standardized pre-
and post-treatment X-ray examination, a pre-treatment
CT scan and MRI exam with contrast agents, and a
follow-up period of at least 6 months. In addition, all pa-
tients who provided written informed consent and com-
pleted a case report form were included in the study.
The case report form consisted of a medical record
evaluation, a self-assessment questionnaire, an interview
and clinical examination, and a standardized radiological
assessment form. We excluded all patients with an in-
complete case report form. All follow-up examinations
were performed in the same hospital by an independent
surgeon not otherwise involved in the study.
Out of the 98 patients treated for KD between 1990
and 2013, 85 % had complete medical data. In 73 % of
the cases, complete questionnaires were returned.
Ninety-three percent of these patients had a clinical
and radiological follow-up examination. In total, 26/46
patients after STT arthrodesis, 14/21 patients after
RSO, 4 out of 7 patients after VBG, and 2 out of 3 pa-
tients after VBG and RSO were available for final re-
view with complete clinical and radiological data.
The operative techniques were performed as previ-
ously described (STT arthrodesis without lunateresection [6], RSO [7], vascularized bone grafts (VBG) of
the 4th extensor compartment artery [8], and palmar
VBG [9]). Post-operative cast immobilization was main-
tained for 6 weeks. All surgeries were performed by ei-
ther one of five plastic surgery-trained hand surgeons or
senior resident/fellow under direct supervision from a
faculty member at one single institution. The treatment
recommendations for STT arthrodesis, RSO, and VBG
were based on previously published expert opinion [10].
Wrist denervation was not performed as an adjunct to
the above surgeries but as a distinct primary or second-
ary procedure in patients excluded from this analysis.
In all cases, the pre-operative diagnosis was confirmed
by one of five plastic surgery-trained hand surgeons and a
consultant radiologist with expertise in musculoskeletal
radiology. Patients were grouped according to the type of
treatment administered (i.e., RSO or STT) (Table 1). In
three patients, RSO was performed in stage IV as a last
resort because the patients did not consent to total wrist
arthrodesis. In these three cases, arthritis was limited to
lunate cartilage.
Medical record evaluation
Data retrieved from the standardized medical records
included the dates of all examinations, the date and
type of treatment, secondary treatments and complica-
tions, pre-treatment active range of motion (ROM),
duration of wrist immobilization, incapacity for work,
and epidemiological data (e.g., age, gender, and handed-
ness). Data were retrieved from the paper-based and
electronic patient records to compensate for missing
data. Inconsistencies were resolved during the interview.
The accuracy and completeness of the case report form
was verified on the occasion of the clinical examination to
avoid missing data and to exclude misunderstandings.
Self-assessment questionnaire
The patients were invited for a follow-up examination,
and a questionnaire was delivered by mail and was re-
sent 6 weeks later to non-responders. Dillman’s total
design method (introductory letter, a self-assessment
questionnaire, and an informed consent form with a
stamped return envelope) was used to maximize
response rates [11]. If no response was received in the
following 6 weeks, the patients were contacted by tele-
phone, and an appointment for the clinical examination
was arranged during which the self-assessment ques-
tionnaire was given to the patient. The questionnaire
was developed by a multidisciplinary team consisting of
one occupational physician, two hand surgeons, one
psychiatrist, and one epidemiologist, as previously
described [1].
Besides demographic, occupational, and medical items,
the questionnaire contained the functional outcome





















Total Total Mean SD Mean No. (%) No. (%) No. (%) No. (%) No. (%)
STT 46 27 4 2.99 37 19 (70) 25 (93) 2 (7) 12 (44) 13 (48)
RSO 21 14 10 7.43 34 9 (64) 12 (86) 2 (14) 4 (29) 8 (57)
VBGc 7 4 1 0.7 38 1 (75) 4 (100) 0 2 (50) 2 (50)
VBGd and
RSO
3 2 4 1.06 29 1 (50) 2 (100) 0 2 (100) 0
Differences
STT vs. RSO p <0.01e 0.87e 0.69f 0.54f 0.49f 0.28f 0.59f
STT scaphotrapeziotrapezoid arthrodesis, RSO radial shortening osteotomy, VBG vascularized bone graft, SD standard deviation
aFull-time work or part-time work (including training/professional training)
bMaternity, unemployed for at most 12 months, or never been employed
cSix palmar and one dorsal VBGs
dOne dorsal and two palmar VBGs
et test
fFisher exact-test
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Hand (DASH) score including the optional work mod-
ule, the Modified Mayo Wrist Score (MMWS). The
query as to whether or not the patient would have the
same operation if he/she were given the same choice,
requiring a simple “yes or no” response and duration of
work incapacity were also included.
Pain was assessed using a Numeric Rating Scale for
Pain (NRS) on an 11-point numeric scale with “0” repre-
senting no pain and “10” representing the worst pain
imaginable at either rest or activity-induced [12].
Interview and clinical examination
The standardized interview assessed duration of work
incapacity, current medication, prior surgery, and med-
ical history. The standardized clinical examination
included active ROM in extension/flexion (E/F), radial/
ulnar (R/U) deviation, pronation/supination (P/S) as
measured with a conventional goniometer, grip strength
as measured with a Biometrics® dynamometer, and ten-
derness and signs of accompanying diseases of the hand
[13]. The grip strength ratio was calculated by dividing
the grip strength in the KD wrist by the contralateral
side to exclude personal factors influencing grip strength
(age and gender biases). To compensate for the effect of
hand dominance, two ratios were calculated: one ratio
when KD affected the non-dominant side: non-dominant/
dominant side and another ratio when KD affected the
dominant side: dominant/non-dominant side.
Radiological assessment
Pre-treatment imaging (including X-ray examination of
both wrists and CT and MRI scans) was retrieved from
the hospital’s digital and conventional X-ray archive, orthe referring surgeons, if necessary. Radiological assess-
ment included pre- and post-treatment Ståhl index (lu-
nate height on lateral view/lunate width on lateral view)
[14], Nattrass index (carpal height on PA view/capitate
height on PA view) [15], radioscaphoid angle using the
tangential method [16], and disease stage according to
Lichtman [17]. Stage IIIB was defined as a radioscaphoid
angle greater than 60° [18]. Stage IV was defined as the
presence of any sign of cartilage damage on the lunate
or the lunate facet on X-ray (joint space narrowing, ir-
regular joint margin, osteophyte formation, cyst forma-
tion, or subchondral sclerosis). Indices and angles were
measured, independently, by three independent board
certified plastic surgeons (hand fellows) using standard-
ized X-rays. A radiological assessment form, with in-
structions and line drawings from the above references,
was given to all examiners. Disagreements were resolved
through consensus. Because STT arthrodesis provides a
stable framework and mechanism for load transference
through the wrist via the capitoscaphoid and radiosca-
phoid joints, thereby, maintaining the carpal height
index stable irrespective of the course of progression of
KD, radiological progression was not assessed after STT
arthrodesis [19].
Statistical analysis
Differences among outcomes were analyzed with the
Fisher’s exact, Wilcoxon test, or the t test, where appro-
priate. P values <0.05 were accepted as statistically sig-
nificant without adjustments for multiple comparisons.
A retrospective power analysis was performed to deter-
mine if the sample size of our study was adequate to
make comparisons between treatment groups. Power
was calculated according to the method of Cohen
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SPSS Version 17 (SPSS Inc., Chicago, IL, USA), SAS 9.2
(SAS Institute Inc. Cary, NC, USA), and SPSS 21 (IBM
Corp, Released 2012, IBM SPSS Statistics for Mac, Ver-
sion 21.0, Armonk. NY: IBM Corp) were used for all
analyses.
Results
Clinical outcomes of STT compared to RSO
There were no significant differences between treatment
groups with regard to age, gender ratio, dominant vs.
non-dominant side affected, and pre-treatment employ-
ment status and occupational activity (Table 1). There
were no significant differences in post-treatment ROM
for E/F, R/U deviation, and P/S between STT arthrodesis
and RSO (Table 2). However, there was a significant
reduction in R/U deviation following STT arthrodesis
and of P/S following RSO or STT arthrodesis. Further-
more, no significant differences were found between the
STT and RSO groups regarding pain at rest or activity-
induced on the NRS, DASH, the MMWS, grip strength,
time to return to work, and the response to the question
regarding whether, if given the choice again, the patient
would have the same operation (Table 3).
Radiological outcomes of RSO or VBG and of RSO and
VBG
Ståhl index, Nattrass index, and radioscaphoid angle did
not significantly change following RSO (Table 4). The
mean pre-operative ulnar variance was −2.8 mm, and
the mean post-operative ulnar variance was −0.43 mm.
Progression of disease stage, according to Lichtman, could
be observed in 10/14 patients following RSO, in 2/4 patients
following VBG, and in 2/2 patients following RSO combined
withVBG (See Figs. 1, 2, 3, 4, 5, 6). There was almost perfect
agreement among the three examiners regarding the Ståhl
index (lunate height ± 1 mm/lunate width ± 1 mm),Table 2 Pre- and post-treatment range of motion (ROM) for all trea
Pre-E/F Post-E/F
Mean SD Mean SD
STT (n = 27) 91° 4.5 83° 16.4
RSO (n = 14) 73° 8.0 93° 42.5
VBG (n = 4) 96° 12.5 70° 55.7
RSO and VBG (n = 2) 115° 15.0 95° 7.1
Post-treatment differences
RSO vs. STT (P value) 0.38a
Estimated clinically relevant difference 30°b
Sample size calculation 66
STT scaphotrapeziotrapezoid arthrodesis, RSO radial shortening osteotomy, VBG vas
ROM was missing in 4/57 cases. The t test was used for statistical analysis. Sample s
test for independent groups, and a clinically relevant difference of 10 % in the high
aWilcoxon test
bEstimation based on functional ranges of motion of the wrist [40]Nattrass index (carpal height ± 1 mm/capitate height ±
1 mm), radioscaphoid angle (±5°), and the KD stage
(agreement of at least two examiners 48/57 (84 %),
53/57 (93 %), 52/57 (91 %), 55/57 (96 %), respectively
(data not shown)).Discussion
We compared the clinical outcomes of STT arthrodesis
to RSO. In addition, we measured the impact of RSO
and vascularized bone grafts (VBG) on disease progres-
sion based on X-ray examinations. Of the 57 patients
examined, we were unable to recognize clinically rele-
vant differences between RSO and STT arthrodesis or
significant radiological differences among RSO, VBG, or
RSO combined with VBG.
No evidence beyond expert opinion has been brought
forward to determine the indications of STT vs RSO. A
US survey has found that most hand surgeons use Licht-
man staging and ulnar variance to guide treatment
decisions [20]. However, an international survey among
hand surgeons has shown that given a stage IIIB accord-
ing to Lichtman and an ulnar variance of −2 mm, 30 %
of the respondents would recommend RSO while 41 %
would recommend STT arthrodesis [21]. The divergent
opinions on the same case may be explained by the
uncertain causal relationship between KD and negative
ulnar variance, which questions the validity of ulnar
variance for guidance of treatment rational [2]. Further-
more, the prognostic value of the Lichtman classification
has been questioned since similar outcomes after RSO
have been found in patients with stage II or IIIA (n = 17)
and IIIB (n = 14) [22]. However, numerous other poten-
tial indication parameters such as age, handedness, years
of active employment, job category, pre-operative range
of motion, and grip strength as well as pre-operative
Ståhl and Nattrass index and radius-scaphoid-angle weretment groups
Pre-R/U Post-R/U Pre-P/S Post-P/S
Mean SD Mean SD Mean SD Mean SD
42° 11.6 33° 9.9 167° 13.5 155° 20.2
37° 10.1 43° 19.8 166° 10.4 149° 17.2
51° 26.6 30° 27.8 165° 19.1 150° 0




cularized bone graft, SD standard deviation
ize per group calculation was based on α = 0.05, power = 80 %, a two-sided t
est score
Table 3 Functional outcomes and complications in all treatment groups










Median SD Mean (%) SD Mean (%) SD Mean SD Mean SD n (%) Mean SD n (%)
STT (n = 27) 1 2 85 23 79 14 44 19 4 1 12 (44) 70 7 24 (89)
RSO (n = 14) 1 1 87 17 66 9 43 19 4 1 3 (21) 71 9 14 (100)
VBG (n = 4) 0 – 99 5 105 – 47 28 2 1 1 (25) 78 10 4 (100)
RSO and VBG (n = 2) 3 – 6 – 78 – 54 11 4 1 0 75 14 0
Post-treatment differences
STT vs. RSO (P value) 0.88e 0.86f 0.19f 0.59f 0.93f 0.19e 0.93f 0.20e
Estimated clinically
relevant difference
2.5g 20 20 20h 2 20 20
Sample size calculation 24 44 18 32 12 192 10
NRS Numeric Rating Scale for Pain, DASH Disabilities of the Arm, Shoulder, and Hand (DASH) score, MMWS Modified Mayo Wrist Score, STT
scaphotrapeziotrapezoid arthrodesis, RSO radial shortening osteotomy, VBG vascularized bone graft, SD standard deviation
aWhen KD affected the dominant side in relation to the non-dominant side
bWhen KD affected the non-dominant side in relation to the dominant side
cAdditional procedures were considered as complications of the first surgery (no hematoma or infections were observed). In the STT group, 12 denervations were
later performed, and in the RSO group 2 denervations and 1 total wrist arthrodesis
d“Yes” response to the question about whether they would have the same operation if they had the choice again
eWilcoxon test
ft test
gEstimation based on clinically important differences in the 0 to 10 Numeric Rating Scale-Pain Intensity
hEstimation based on DASH data of non-clinical vs. clinical groups of persons aged 30–49 years (Jester et al. 2010 [41])
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2, and 4).
Strengths and weaknesses of the study
Rigorous criteria limited the inclusion rate but provided
adequate data sampling, collection, and analysis thereby
improving the quality and validity of our study. To
minimize the incidence of false-positive diagnosis of KD,
we included only patients with confirmed diagnoses on







Median SD Median SD Median SD
STT (n = 27) 0.37 0.07 0.32 0.08 0.70 0.
RSO (n = 14) 0.37 0.1 0.32 0.11 0.70 0.
VBG (n = 4) 0.48 0.1 0.44 0.09 0.69 0.
RSO and VBG (n = 2) 0.39 0.04 0.30 0.07 0.72 0.
Pre- to post-treatment
differences
RSO (P value) 0.21a 0.67a
VBG (P value) 1.00a 0.32a




Sample size calculation 42 24
STT scaphotrapeziotrapezoid arthrodesis, RSO radial shortening osteotomy, VBG vas
aWilcoxon testexaminations as independently assessed by a board certi-
fied plastic surgeon and a musculoskeletal radiologist.
Because KD is not well understood, questions persist
as to which parameter is adequate to measure disease
progression. The Nattrass and Ståhl indices and the
radius-scaphoid-angle have been widely used for radio-
logical evaluation of KD because of good intra-observer
reliability [15, 23]. The specificity and sensitivity of these
parameters for any change intended by the treatment is
unknown although the independent evaluation of theseters evaluating KD progression in all treatment groups
s Post-Nattrass
index Pre-radius-scaphoid-angle Post-radius-scaphoid-angle
Median SD Median SD Median SD
06 0.69 0.04 59° 6.11 51° 5.35
06 0.71 0.08 56° 7.71 63° 5.58
01 0.69 0.01 62° 7.48 64° 8.49






cularized bone graft, SD standard deviation
Fig. 1 Pre-operative pa x-rays of the right wrist of a 31-year-old male
patient who had undergone RSO Fig. 3 Pre-operative x-rays of the right wrist of of a 45-year-old male
patient who had undergone STT arthrodesis
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mized observer bias. However, a bias due to inappropri-
ate or imperfect reference standard cannot be ruled out
when evaluating the radiological outcome of KD.
Because of a lack of scientific evidence revealed in re-
cent studies for a causal association between KD and
negative ulnar variance [2], RSO has not been performed
after 2009, leading to an overall longer follow-up. A
retrospective study on RSO for KD has suggested that
no relevant differences in clinical outcomes occurred in
22 patients at 5 and 10 years follow-up [24]. Our litera-
ture review did not suggest a unidirectional change in
outcome measures after STT arthrodesis for KD between
medium- and long-term periods (Table 6). Nevertheless,Fig. 2 Post-operative pa x-rays of the right wrist of a 31-year-old
male patient who had undergone RSOthe difference in follow-up periods of patients after STT
arthrodesis or RSO may have influenced statistical sig-
nificance. Further studies are needed to determine if
clinical changes are significant between medium- and
long-term periods and whether or not these differences
are clinically relevant for the patient.
Demographic parameters and stage distributions
were comparable among all treatment groups except
when comparing the pre-operative stages in the RSO
group and in the RSO and VBG groups. However,
group classification according to the initial stage of KD
was not performed for the following reasons: (1) it has
been previously suggested that initial KD stage, ac-
cording to Lichtman, has no influence on treatmentFig. 4 Post-operative x-rays of the right wrist of of a 45-year-old
male patient who had undergone STT arthrodesis
Fig. 5 Pre-operative x-rays of the left wrist of of a 44-year-old male
patient who had undergone VBG
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tions has been questioned because arthritis of the lu-
nate can be observed in the absence of lunate fracture
or carpal collapse [1]; (3) the reliability and comparability
of KD stages in literature is limited because no distinction
is generally made regarding the localization of arthritis (lu-
nate cartilage, lunate facet, or the entire radiocarpal joint)
and because there is no consensus regarding the diagnos-
tic requirements for KD and associated arthritis (X-ray,Fig. 6 Post-operative x-rays of the left wrist of of a 44-year-old male
patient who had undergone VBGMRI, CT scan, or arthroscopy) [1]; (4) because KD may
progress from a preserved lunate shape to fragmentation
within 6 months [1], staging may not be accurate if more
than 4 weeks have elapsed between diagnosis and surgery;
(5) a correlation between radiological parameters of KD
classifications and the clinical course has not been estab-
lished, while many authors have observed a poor correl-
ation with clinical findings [27, 28].
Given the retrospective nature of this comparative
study, the treatment decisions for STT arthrodesis, RSO,
and VBG were not defined in advance but based on pre-
viously published expert opinion [10] and reflect the
variability in treatment recommendations among hand
surgeons [20, 21].
The inability to accrue enough patients to generate
high statistical power in clinical trials is a problem com-
mon to all rare diseases. Because of this challenge,
underpowered but well-conducted large studies provide
the best available data until a meta-analysis may be con-
ducted to provide results with higher statistical power.
We believe that the descriptive statistics and the review
of literature are informative enough to open a debate on
the achievable goals in surgical treatment of KD.
Clinical outcomes
A systematic review of 175 non-comparative case series
on KD treatment outcomes showed an increasing trend
towards recommending a surgical procedure for KD [5].
However, comparative studies reported comparable results
from surgical treatment and, therefore, their conclusions
were more cautious [27–33] (Table 5). A meta-analysis
suggested that there was insufficient data to determine the
superiority of any intervention compared to placebo or
the natural history of the disease [4].
No significant differences were found in a follow-up
examination of 33 conservatively treated patients be-
tween stages II, IIIA, IIIB, and IV regarding ROM,
DASH score, pain, or grip strength although the DASH
score seemed to improve spontaneously in patients who
had experienced symptoms for longer than 10 years [28].
The homogenous clinical outcomes of surgically treated
patients may be due to partial wrist denervation during
the procedures, limited specificity and sensitivity of out-
come parameters, the relatively benign spontaneous
course, insufficient statistical power, or a placebo effect.
A 5-month follow-up examination of 17 patients after
arthroscopic débridement and partial wrist denervation
reported decreased pain in 11/17 of the patients [34].
Because there was no evidence that arthroscopy cured
or arrested osteonecrosis, the effect may have been due
to either partial wrist denervation or to a placebo effect,
as previously described in arthroscopic surgery [35].
The lack of clinically relevant differences in treatment
outcomes following RSO or STT arthrodesis, as shown




of wrists with KDd)
Follow-up in
years (SD)
Post-op pain Post-op DASH
without work
module
Post-op E/F Incapacity for
work (weeks)




Chart review RSO (9/9) 6.4 ± 1.8 NM NM NM NM None
Examination VBG (7/7) 6.5 ± 1.6 NM NM NM NM
Martin, 2013
[43]
DASH only Conservative (44/44) NM NM 23.7 ± 24.5 NM NM None
Partial wrist fusion
(11/11)







Chart review STT (8/8) 1 VAS at restb, 28 ± 31 21 ± 16 56° ± 16 NM Better E/F and R/U after PRC
VAS activity-inducedb, 30 ± 27
Examination PRC (11/11) 1 VAS at restb, 16 ± 29 19 ± 20 80° ± 23 NM




Chart review Conservative (19/59) 12 Pain quality and duration 21 92° 2.6 Less pain, better ROM, faster return to
work after conservative treatment
Examination STT (11/25) 14 Pain quality and duration 17 74° 17.1
Das Gupta,
2003 [46]
Examination STT (13/13) 1.9 NM 19 68° NM NM
RSO (20/42) 6.9 NM 14 106° NM
Salmon, 2000 Chart review Conservative (15/18) NM NRS at restb, 2.8 NM NM NM NM
NRS at worstb, 3
Examination RSO (14/15) NM NRS at restb, 0.5 NM NM NM
NRS at worstb, 7.6
Nakamura, 1998
[48]
Chart review PRC (7/7) 6.7 Pain yes/no NM 64° NM None






Chart review Conservative (22/22) 5.4 Pain quality and duration NM 97° NM Better ROM after conservative treatment





















Chart review RSO (14/15) 5.2 NM – NM NM Better clinical outcome after RSO
according to own wrist scoring system
Examination STT (9/9) 4.5 NM – NM NM
Kristensen,
1986 [51]
Chart review Immobilization (23/23) 23 VRSa (0–3), 2 ± 0.7 – NM NM NM
Examination No specific treatment
(24/24)
18.2 VRSa (0–3), 2 ± 0.7 – NM NM
Evans, 1986
[52]
Chart review Conservative (14/14) 1.8 VRSa (0–3), 1 ± 0.7 – 68° NM NM
Examination Silastic arthroplasty
(21/21)
3.2 VRSa (0–3), 1 ± 0.8 – 69° NM
Beckenbaugh,
1980 [53]
Chart review Conservative (7/10) 7 No patient had pain – 89° NM None
Examination Silastic arthroplasty
(22/22)
3.8 No patient had pain – 75° NM
Stahl, 2015 [54] Chart review STT (27/46) 4b ± 3c NRS at rest, 0a ±2 c 44.3b ± 19c 83°b ± 16c 4b ± 3c None
NRS activity-induced, 5a ±2c
Questionnaire RSO (14/21) 10b ± 7.4c NRS at rest, 1a ± 1c 43.9b ± 19c 93°b ± 42c 5b ± 3c
Examination NRS activity-induced, 6a ±2 c
NRS Numeric Rating Scale for Pain (0–10), VAS visual analog scale (0–100), VRS verbal rating scale, NM not mentioned, Δ Difference between pre- and post-treatment values, PRC proximal row carpectomy, STT




dTen out of 12 of the reviewed studies did not mention if the data were collected prospectively in a follow-up examination for the purpose of a clinical study or if the data were assessed on the occasion of clinical













Stahl et al. Journal of Orthopaedic Surgery and Research  (2015) 10:133 Page 10 of 12in our study, compares well with previous comparative
studies (Table 5) and the outcomes of these procedures
as predicted by 126 surgeons in an international survey
in 2009 and 2010 [21]. Although different scales were
used, no striking difference regarding post-treatment
pain was observed. The scores measured with the official
DASH suggested worse functional outcomes in com-
parison with other comparative studies. However, un-
certainty remains regarding whether the DASH cut
points were appropriate for different populations at an
individual level [36]. Despite its wide usage, the DASH
has some limitations. With respect to question No. 18
of the DASH questionnaire, for example, none of the
patients in our study could relate to forceful recre-
ational activities associated with golfing, while the com-
parison of the level of intensity of golf and hammering
may seem questionable. In addition, question No. 20
leaves room for interpretation as to whether difficulties
in managing transportation need to include biking orTable 6 Review of radiological outcomes after RSO and/or VBG stud
Treatment (inclusion















VBG (10/10) NM −0.004
Watanabe,
2008 [57]
RSO (13) 21 −0.03b
Wada, 2002
[58]






RSO (9) 2.6 0
Moran,
2002 [60]
VBG (26) 2.6 0.02c
Wintman,
2001 [61]






Δ carpal height, −0.7 mm
Δ lunate width, +2.0 mm
RSO (14/15) NM Δ carpal height, −0.7 mm
Δ lunate width, +2.4 mm
Stahl, 2015
[54]
RSO (14/21) 10.5 ± 7.4 −0.03
VBG (4/7) 1.2 ± 0.7 −0.04
VBG and RSO (2/3) 3.9 ± 1.1 −0.09
Δdifference between pre- and post-treatment values, NM not mentioned, STT scaphotr
bone graft
aNattrass Index
bP < 0.05 in pre- and post-treatment comparison
cNo specification if pre-treatment values increased or decreased by the cited figure
dCombined with cancellous bone graftpublic transportation. Due to the heterogeneous meas-
urement of grip strength in the reviewed literature, no
comparisons were possible.
Radiological outcomes
Differences of 3 to 6 % between pre- and post-operative
radiological measurements are of questionable relevance
(Table 6). Interestingly, the few studies on RSO with
clinical and radiological assessment reported satisfactory
clinical results in the face of KD progression upon X-ray
evaluation [26, 37, 38]. Relevant and significant differ-
ences have not been reported in comparative studies. In
an uncontrolled evaluation of one radiologist after VBG,
suggesting revascularization in 12/17 cases on T1-
weighted and/or T2-weighted MRI, no efforts were
made to reduce the risk of bias [39]. Indeed, vaguely
defined radiological parameters of unknown reliability
and measurements of one single unblended observer are






Significant difference in radiological















apeziotrapezoid arthrodesis, RSO radial shortening osteotomy, VBG vascularized
s
Stahl et al. Journal of Orthopaedic Surgery and Research  (2015) 10:133 Page 11 of 12The sample sizes of VBG (n = 4) and VBG and RSO
(n = 2) allow for a descriptive analysis but not the testing
of statistical hypotheses. Statistical comparison of clinical
outcome parameters was therefore performed between
STT (n = 27), which aims to prolong wrist function, and
RSO only (n = 14). However, because the radiologic pa-
rameters in this study and in the reviewed literature did
not suggest a relevant improvement of KD after RSO or
VBG, an improvement of wrist function seems unlikely
even in a larger cohort.
Conclusions
No evidence has been found that the progression of KD
can be stopped or reversed by either RSO or VBG. No
relevant clinical differences were found following STT
arthrodesis or RSO in patients with KD. This study has
shown that comparative studies are very rare and that
most report negative results. A systematic review has
shown that the vast majority of publications on KD are
case series, most reporting positive results [5]. Since fund-
ing is not easily obtained for research on rare diseases,
and even less for non-life threatening diseases, random-
ized controlled trials are unlikely to be conducted in the
near future. In the absence of randomized controlled
trials, surgeons may be particularly vulnerable to a bias
towards publishing positive results in case series of KD.
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